Frank Baaijens is a full professor of Soft Tissue Biomechanics and Tissue Engineering at Eindhoven University of Technology (TU/e). His areas of expertise include computational (bio)mechanics, rheology and regenerative medicine. Frank Baaijens currently serves as Rector Magnificus at TU/e. His focus is building on the TU/e’s strengths with the entire community, strengthening the university’s international position and working on finding solutions to current and future societal challenges, bridging education and research. Frank Baaijens is committed to the future vision and mission of TU/e, outlined in the strategy 2030 plan. This plan aims to further excellence of the university in education and research, and impact on society. The university will strengthen its foundations, foster cross-disciplinary research, and will continue to innovate our educational methods and programs to educate next generations of engineers and scientists.

It is incredibly rewarding to witness the personal and professional growth of young talent when they are engaged in academic education and research


Frank Baaijens received his PhD from TU/e in 1987. In 1985 he joined Philips Research Laboratories in Eindhoven to work on Computational Mechanics. Since 1990, he has been part time professor on Computational Rheology at the Eindhoven University of Technology. In July 1995 he was appointed full professor in the Department of Mechanical Engineering. In October 2002 he was appointed full professor in the Department of BioMedical Engineering (Soft Tissue Biomechanics and Tissue Engineering). From 2003 to 2007 he was Dean of the Department of Biomedical Engineering, and from 2007 to 2014 he was Scientific Director of the national research program on BioMedical Materials (BMM).  The first half of his career was dedicated to computational rheology with emphasis on the analysis of viscoelastic flows of polymer solutions and melts. The switch to biomedical engineering changed his research focus to regenerative medicine, and in particular the engineering of living heart valves. Based on this research a number of biomedical technology companies were founded resulting in clinical applications.    

  • Numerical Analysis of Continua II

Ancillary Activities

  • Bezit aandelen, Xeltis AG
  • Lid Stichting Bestuur, HOVO Brabant Seniorenacademi
  • Lid wetenschappelijke adviesraad, Imperal college
  • Lid, Stuurgroep Solliance
  • Lid regiegroep, Topsector LSH
  • Lid bestuur HTSM, Topsector HTSM
  • Voorzitter Kennisprogramma Effecten Mijnbouw, EZK
  • Lid Strategische Adviesraad, TNO
  • Visiting professor, University of Zurich
  • Lid bestuur, Stichting Biomedical Materials Consortium
  • Bestuurslid, Frits Philips Foundation
  • Bestuurslid, Stichting Biomedical Materials Consortium